Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Total Liabilities (2016 - 2025)

Cellectis (CLLS) has 8 years of Total Liabilities data on record, last reported at $143.2 million in Q4 2022.

  • For Q4 2022, Total Liabilities rose 164.73% year-over-year to $143.2 million; the TTM value through Dec 2022 reached $143.2 million, up 164.73%, while the annual FY2022 figure was $143.2 million, 164.73% up from the prior year.
  • Total Liabilities reached $143.2 million in Q4 2022 per CLLS's latest filing, up from -$221.3 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $143.2 million in Q4 2022 and bottomed at -$283.8 million in Q4 2020.
  • Average Total Liabilities over 4 years is -$67.6 million, with a median of -$64.9 million recorded in 2018.
  • Peak YoY movement for Total Liabilities: grew 22.02% in 2021, then skyrocketed 164.73% in 2022.
  • A 4-year view of Total Liabilities shows it stood at $91.5 million in 2018, then tumbled by 410.03% to -$283.8 million in 2020, then increased by 22.02% to -$221.3 million in 2021, then surged by 164.73% to $143.2 million in 2022.
  • Per Business Quant database, its latest 3 readings for Total Liabilities were $143.2 million in Q4 2022, -$221.3 million in Q4 2021, and -$283.8 million in Q4 2020.